Diagnostics (Oct 2022)

PSMA PET-CT in the Diagnosis and Staging of Prostate Cancer

  • Alexander D. Combes,
  • Catalina A. Palma,
  • Ross Calopedos,
  • Lingfeng Wen,
  • Henry Woo,
  • Michael Fulham,
  • Scott Leslie

DOI
https://doi.org/10.3390/diagnostics12112594
Journal volume & issue
Vol. 12, no. 11
p. 2594

Abstract

Read online

Prostate cancer is the most common cancer and the second leading cause of cancer death in men. The imaging assessment and treatment of prostate cancer has vastly improved over the past decade. The introduction of PSMA PET-CT has improved the detection of loco-regional and metastatic disease. PSMA PET-CT also has a role in the primary diagnosis and staging, in detecting biochemical recurrence after curative treatment and in metastasis-directed therapy. In this paper we review the role of PSMA PET-CT in prostate cancer.

Keywords